CSNK1A1 and COVID-19: Microthrombi-positive versus microthrombi-negative COVID-19 comparisons yielded 4 tier 1 targets: PIP5K1A, STAT3, and VEGFA in fibroblasts and CSNK1A1 in pericytes.